Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD

Clinical trial NCT04913389 · UNKNOWN

Trial details

NCT number: NCT04913389
Sponsor: University of Zurich
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease Altitude Sickness Altitude Hypoxia

Start date: 2021-06-01
Primary completion: 2022-08-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.